Summary & Overview
HCPCS G9577: Patients Prescribed Opiates Longer Than Six Weeks
HCPCS Level II code G9577 captures patients who have been prescribed opioid medications for longer than six weeks. The code is intended to flag ongoing opioid therapy and supports monitoring, reporting, and care coordination efforts related to long-term opioid use. Nationally, tracking prolonged opioid prescriptions is a priority for quality measurement, utilization management, and population health programs that aim to balance pain management and opioid safety.
Key payers in this context typically include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code's clinical context, typical service settings, and relevance for payer policies. The publication outlines benchmarking opportunities, common billing and documentation considerations, and how payers may incorporate the code into utilization review and quality reporting frameworks. Where specific payer policies or coverage determinations exist, those are summarized; otherwise, the report notes that payer-specific guidance is variable.
This summary provides clinicians, billing professionals, and policy analysts with a concise reference to the purpose and application of HCPCS Level II code G9577, helping stakeholders understand its role in managing and monitoring patients on extended opioid therapy.
Billing Code Overview
HCPCS Level II code G9577 denotes patients prescribed opiates for longer than six weeks. This code is used to identify and document ongoing opioid therapy beyond the six-week mark, reflecting continued opioid prescribing and monitoring needs.
-
Service Type: Ongoing opioid therapy management
-
Typical Site of Service: Outpatient clinic or ambulatory care settings where long-term opioid prescribing is managed
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient with chronic low back pain has been prescribed opioid therapy daily for more than six weeks by a primary care physician. The patient presents to a pain management clinic for a follow-up visit for continued opioid prescribing, medication review, and risk assessment. The clinical workflow includes review of the opioid treatment history, assessment of pain control and functional status, evaluation for opioid-related adverse effects, screening for opioid use disorder risk (including screening tools and review of state prescription drug monitoring program), documentation of informed consent and treatment plan, consideration of urine drug testing, and discussion of tapering or alternative therapies if clinically indicated. The visit may result in continuation of the opioid prescription with documentation meeting chronic opioid therapy standards, initiation of additional monitoring (for example, urine drug screen), referral to specialty behavioral health or addiction medicine, or modification of the treatment plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When additional work or time beyond typical visit is required for complex opioid management documentation |
23 |